Skip to main content

Table 5 MiRNAs commonly deregulated in CRC clinical samples and CRC cell lines.

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

miRNA

fold change

location

CRC Fragile site*

hsa-miR-20a

up

13q31.3

gain

hsa-miR-19a

up

13q31.3

gain

hsa-miR-17-5p

up

13q31.3

gain

hsa-miR-93

up

7q22.1

gain

hsa-miR-25

up

7q22.1

gain

hsa-miR-31

up

9p21.3

 

hsa-miR-106a

up

Xq26.2

 

hsa-miR-143

down

5q32

loss

hsa-miR-145

down

5q32

loss

hsa-miR-125a

down

19q13.41

gain

hsa-miR-1

down

18q12.3 or 20q13.33

loss (18q) or gain (20q)

  1. * Summarized from [41–43]